Feasibility, acceptability and preliminary efficacy of an online peer-to-peer social support ART adherence intervention

AIDS and Behavior

Volumn 17, Issue 6, 2013, Pages 2031-2044

  Horvath, Keith J ^a   Michael Oakes, J ^b   Simon Rosser, B R ^b   Danilenko, Gene ^c   Vezina, Heather ^d   Rivet Amico, K ^e   Williams, Mark L ^f   Simoni, Jane ^g  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c Xerebral Inc   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF CONNECTICUT   (United States)

^f FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^g UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Antiretroviral adherence; Internet based intervention; Men who have sex with men; Social support

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; BISEXUALITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEASIBILITY STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERNET; MALE; MALE HOMOSEXUALITY; MEDICATION COMPLIANCE; PATIENT SATISFACTION; PEER GROUP; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; SOCIAL SUPPORT;

ADULT; ANTI-HIV AGENTS; BISEXUALITY; FEASIBILITY STUDIES; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; INTERNET; MALE; MEDICATION ADHERENCE; PATIENT SATISFACTION; PEER GROUP; SOCIAL SUPPORT;

EID: 84879017364     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-013-0469-1     Document Type: Article

References (37)

1. The Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372(9635):293-9.
2. Cohen MS, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493-505.
3. Prejean J, et al. Estimated HIV incidence in the United States, 2006-2009. PLoS One. 2011;6(8):e17502.
4. Centers for Disease Control and Prevention, HIV Surveillance Report: Diagnoses of HIV Infection and AIDS in the United States and Dependent Areas, 2010, 2012.
5. Mills EJ, et al. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med. 2006;3(11):e438.
6. Mugavero MJ, et al. Failure to establish HIV care: characterizing the "no show" phenomenon. Clin Infect Dis. 2007;45(1):127-30.
7. Simoni J, et al. Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S23-35.
8. Simoni J, et al. Antiretroviral adherence interventions: a review of current literature and ongoing studies. Top HIV Med. 2003;11(6):185-98.
9. Thompson MA, et al. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an international association of physicians in AIDS care panel. Ann Intern Med. 2012;156(11):817-33.
10. Saberi P, Johnson MO. Technology-based self-care methods of improving antiretroviral adherence: a systematic review. PLoS One. 2011;6(11):e27533.
11. Page TF, et al. A cost analysis of an internet-based medication adherence intervention for people living with HIV. J Acquir Immune Defic Syndr. 2012;60(1):1-4.
12. Pellowski JA, Kalichman SC. Recent advances (2011-2012) in technology-delivered interventions for people living with HIV. Curr HIV/AIDS Rep. 2012;9(4):326-34.
13. Fisher JD, et al. Computer-based intervention in HIV clinical care setting improves antiretroviral adherence: the LifeWindows project. AIDS Behav. 2011;15(8):1635-46.
14. Portnoy DB, et al. Computer-delivered interventions for health promotion and behavioral risk reduction: a meta-analysis of 75 randomized controlled trials, 1988-2007. Prev Med. 2008;47(1):3-16.
15. Noar SM, Black HG, Pierce LB. Efficacy of computer technology-based HIV prevention interventions: a meta-analysis. AIDS. 2009;23(1):107-15.
16. Madden M, Zickuhr K. 65 % of online adults use social networking sites. 2011. http://pewinternet.org/Reports/2011/Social-Networking-Sites.aspx, Pew Research Center: Washington DC.
17. Fox S. Peer-to-peer healthcare: many people-especially those living with chronic or rare diseases-use online connections to supplement professional medical advice. Washington DC: Pew Research Center's Internet & American Life Project; 2011.
18. Horvath K, et al. Technology use and reasons to participate in social networking health websites among people living with HIV in the US. AIDS Behav. 2012;16(4):900-10.
19. Rosser BS, et al. Reducing HIV risk behavior of men who have sex with men through persuasive computing: results of the Men's INTernet Study-II. AIDS. 2010;24(13):2099-107.
20. Potosky D. The internet knowledge (iKnow) measure. Comput Hum Behav. 2007;23(6):2760-77.
21. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1992;1:385-401.
22. Zhang W, et al. Validating a shortened depression scale (10 item CES-D) among HIV-positive people in British Columbia, Canada. PLoS One. 2012;7(7):e40793.
23. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24:385-96.
24. Wong MD, et al. The association between life chaos, health care use, and health status among HIV-infected persons. J Gen Intern Med. 2007;22(9):1286-91.
25. Emlet CA. Measuring stigma in older and younger adults with HIV/AIDS: an analysis of an HIV stigma scale and initial exploration of subscales. Res Soc Work Pract. 2005;15:291-300.
26. Saunders JB, et al. Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction. 1993;88(6):791-804.
27. DeLone WH, McLean ER. The DeLone and McLean model of information systems success: a ten-year update. J Manag Inf Syst. 2003;19(4):9-30.
28. DeLone WH, McLean ER. Information systems success: the quest for the dependent variable. Inf Syst Res. 1992;3(1):60-95.
29. Simoni J, et al. Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10(3):227-45.
30. Walsh JC, Mandalia S, Gazzard BG. Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS. 2002;16(2):269-77.
31. Begg C, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA. 1996;276(8):637-9.
32. Dimitrov DM, Rumrill PD Jr. Pretest-posttest designs and measurement of change. Work. 2003;20(2):159-65.
33. Gottman JM, Rushe RH. The analysis of change: issues, fallacies, and new ideas. J Consult Clin Psychol. 1993;61(6):907-10.
34. Bangsberg DR, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15(9):1181-3.
35. Pasternak AO, et al. Modest non-adherence to antiretroviral therapy promotes residual HIV-1 replication in the absence of virological rebound in plasma. J Infect Dis. 2012;206(9):1443-52.
36. Rivet Amico K, Harman JJ, Johnson BT. Efficacy of antiretroviral therapy adherence interventions: a Research Synthesis of Trials, 1996 to 2004. J Acquir Immune Defic Syndr. 2006;41(3):285-97.
37. Anderson PL, et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012;4(151):151ra125.